GlobeNewsWire
30 Jun 2026, 16:51 UTC · 18w ago
Impact · against what's priced in
UNCY faces a severe valuation hit due to a second FDA rejection and subsequent legal investigation. VHUB and WLTH are subject to separate investigations by the same law firm, creating new legal overhangs for both companies.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish
The FDA issued a second Complete Response Letter (CRL) regarding Unicycive Therapeutics' resubmitted OLC NDA.
So whatA second CRL indicates a failure to gain regulatory approval for a key product, significantly delaying potential revenue and impacting company valuation.
More negative than 99% of claims this week
The FDA's rejection was based on recurring third-party manufacturing deficiencies and a lack of a completed vendor inspection.
Continue reading
5 related stories
The receipt of a second CRL for the OLC NDA due to recurring manufacturing deficiencies and the lack of a vendor inspection significantly delays potential revenue and triggers a securities law investigation.
Read from the article alone
No priced-in read yet
The company is now under investigation by Johnson Fistel on behalf of investors who suffered losses, introducing potential litigation costs.
Read from the article alone
No priced-in read yet
The company is under investigation by Johnson Fistel regarding investor losses, creating a new legal risk factor.
Read from the article alone
Scored by the NIS engine · methodology.
Search tags
More negative than 94% of claims this week
Law firm Johnson Fistel is investigating Unicycive Therapeutics for potential securities law violations following investor losses.
More negative than 87% of claims this week
Which stocks this story touches
More negative than 99% of ticker scores this week
The company received a second FDA Complete Response Letter due to manufacturing deficiencies, leading to a stock price decline and a legal investigation.
More negative than 92% of ticker scores this week
The company is the subject of an investigation by Johnson Fistel on behalf of investors who suffered losses.
More negative than 92% of ticker scores this week
The company is the subject of an investigation by Johnson Fistel on behalf of investors who suffered losses.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
3h ago
−76.0%
Price agrees with the score
$0.2544 vs $1.06 close before publication (Jun 29) · not market-adjusted
VHUB chart →−53.6%
Price agrees with the score
$3.57 vs $7.70 close before publication (Jun 29) · not market-adjusted
UNCY chart →+15.3%
Price is moving against the score
$10.44 vs $9.05 close before publication (Jun 29) · not market-adjusted
WLTH chart →
